Contact Us for Special Offers and Discounts!

HomeShopPharmaceutical TabletsQarziba Injection ( Dinutuximab )

Qarziba Injection ( Dinutuximab )

Marketer
EUSA Pharma
SALT COMPOSITION
Dinutuximab
Storage
Store below 30°C
[2°C to 8°C (36°F to 46°F)].

Rs. 250,000.00

Add to wishlist

Description

Dinutuximab injection may cause serious or life-threatening reactions that may occur while the medication is being given or up to 24 hours afterward. A doctor or nurse will watch your child closely while receiving the infusion and for at least 4 hours afterwards to provide treatment in case of a serious reaction to the medication. Your child may be given other medications before and while receiving dinutuximab to prevent or manage reactions to dinutuximab. Tell your doctor immediately if your child experiences any of the following symptoms during your infusion or up to 24 hours after your infusion: hives; rash; itching; reddening of the skin; fever; chills; difficulty breathing or swallowing; swelling of the face, throat, tongue, or lips; dizziness; faintness; or a fast heartbeat.

Dinutuximab injection can cause damage to nerves that may result in pain or other symptoms. Your child may receive pain medication before, during, and after the dinutuximab infusion. Tell your child’s doctor or other health care provider(s) immediately if they experience any of the following symptoms during and after the infusion: severe or worsening pain, particularly in the stomach, back, chest, muscles or joints or numbness, tingling, burning, or weakness in the feet or hands.

Keep all appointments with your child’s doctor and the laboratory. Your doctor may order certain tests to check your child’s response to dinutuximab injection.

Reviews

There are no reviews yet.

Be the first to review “Qarziba Injection ( Dinutuximab )”

Your email address will not be published. Required fields are marked *

× How can I help you?